The Advanced Research Projects Agency for Health, an agency within the U.S. Department of Health and Human Services, published a new program on January 13, 2026, with an ambitious target: building the ...

In September 2025, the FDA approved an updated label for Krystal Biotech’s beremagene geperpavec-svdt (B-VEC/YJUVEK), reflecting evolving treatment guidance for epidermolysis bullosa and reinforcing ...

Epilepsy affects roughly 50 million people worldwide, yet the genetic roots of its most common forms have remained stubbornly obscure. A new mini-review published in Genomic Psychiatry brings together ...

BridgeBio Pharma, Inc. recently announced that interim Phase 3 FORTIFY trial data for BBP-418 in limb-girdle muscular dystrophy type 2I/R9 met efficacy endpoints, with expanded results to be presented ...

When the performance of AI models was assessed within stratified patient subgroups, such as only high-grade breast cancers or only MSI-positive tumors, accuracy fell substantially, revealing that the ...

Stroke is one of the leading causes of death and disability worldwide, making early screening and risk prediction crucial. Traditional methods have limitations in handling nonlinear relationships ...

AI is the broad goal of creating intelligent systems, no matter what technique is used. In comparison, Machine Learning is a specific technique to train intelligent systems by teaching models to learn ...

ABSTRACT: Smart health refers to the integration of cutting-edge technologies into healthcare systems to improve patient care and apply intelligent clinical decision-making. The study investigates how ...

Chronic Coronary Disease (CCD) is a leading global cause of morbidity and mortality. Existing Pre-test Probability (PTP) models mainly rely on in-hospital data and clinician judgment. This study aims ...

10 The George Institute for Global Health, School of Public Health, Imperial College London, London, UK Background Cardiovascular risk is underassessed in women. Many women undergo screening ...